Keith Crandell
QuietNamed in filings at ARCH Venture PartnersOn the current fund
- Board seats filed
- 11
Named in filings at ARCH Venture PartnersOn the current fund
all filings on record
last 24 months
from a verified or cited source
| Vizgen | Biotech & pharma | March 2021 | Novalis Lifesciences Investments |
| Cytrellis Biosystems | Medical devices | December 2020 | None on file |
| Ultivue | Biotech & pharma | July 2017 | None on file |
| Arbor Biotechnologies | Biotech & pharma | May 2017 | Novalis Lifesciences Investments, TCG Crossover, Tcgx Asia Life Sciences, Vivo Innovation |
| 908 Devices | Robotics & hardware | April 2015 | None on file |
| NANOSYS | Manufacturing & industrials | February 2015 | None on file |
| PixelEXX Systems | Medical devices | November 2013 | None on file |
| Twist Bioscience | Biotech & pharma | July 2013 | None on file |
| ADESTO TECHNOLOGIES | Robotics & hardware | September 2012 | None on file |
| Quanterix | Biotech & pharma | March 2012 | Bain Capital Ventures, Novalis Lifesciences Investments |
| Univa | AI & machine learning | February 2012 | None on file |
The company and date are what the SEC filing shows, not a statement of investment thesis. A partner can sit on a board for reasons that say nothing about what their firm funds today. The sector is not a filing value: it is Lev’s own classification of each company, shown only when we found a specific, checkable source for it; otherwise it reads “Not yet classified.” “Also on the board from” names another tracked firm with a partner on the same board, both with a clean identity match. It is not a claim either firm led or co-led the round, and “None on file” means no other tracked firm’s partner shares this specific board seat, not that no one else invested. Sorted newest first by default; click a column to change it. Something wrong? Tell us.
Classified sectors of companies where filings name Keith Crandell on the board, based on 11 filed seats with a verified or cited source.